当前位置:首页 - 行情中心 - 吉大正元(003029) - 财务分析 - 利润表

吉大正元

(003029)

  

流通市值:37.70亿  总市值:41.45亿
流通股本:1.76亿   总股本:1.94亿

利润表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、营业总收入61,692,422.56406,660,357.76232,093,958.58177,258,985.26
  营业收入61,692,422.56406,660,357.76232,093,958.58177,258,985.26
二、营业总成本84,767,111.83461,975,560.79295,203,867.91208,283,993.78
  营业成本27,983,092.46188,891,391.799,967,317.278,912,656.98
  税金及附加2,018,138.456,787,438.545,350,947.83,259,171.57
  销售费用29,344,682.82143,594,890.7898,648,593.5764,710,725
  管理费用14,575,483.0669,801,455.8351,003,773.4433,873,379.57
  研发费用10,384,360.6352,574,555.1139,276,960.2626,881,782.75
  财务费用461,354.41325,828.83956,275.64646,277.91
  其中:利息费用583,198.251,392,209.61,648,445.241,731,667.4
  其中:利息收入171,619.471,344,3403,553,418.861,212,578.63
三、其他经营收益
  加:投资收益-465,457.36-361,022.03-1,710,647.96-2,740,242.76
  资产处置收益-201,080.34108,817.1833,586.66
  资产减值损失(新)-16,027.29-27,764,508.5-699,723.87-114,367.28
  信用减值损失(新)11,136,387.53-30,814,760.71-6,356,140.28-8,182,427.75
  其他收益1,299,686.679,275,168.756,452,216.153,167,392.63
四、营业利润-11,120,099.72-104,779,245.18-65,315,388.11-38,861,067.02
  加:营业外收入211,437,339.2519,778.22823.2
  减:营业外支出70,287.81153,703.3444,807.9640,761.52
五、利润总额-11,190,366.53-103,495,609.27-65,340,417.85-38,901,005.34
  减:所得税费用362,209.28-3,366,800.24-3,059,041.77-1,956,962.82
六、净利润-11,552,575.81-100,128,809.03-62,281,376.08-36,944,042.52
(一)按经营持续性分类
  持续经营净利润-11,552,575.81-100,128,809.03-62,281,376.08-36,944,042.52
(二)按所有权归属分类
  归属于母公司股东的净利润-13,428,863.82-114,401,033.12-73,617,048.63-43,131,623.44
  少数股东损益1,876,288.0114,272,224.0911,335,672.556,187,580.92
  扣除非经常损益后的净利润-14,167,291.98-124,033,631.09-77,901,809.55-44,858,657.04
七、每股收益
  (一)基本每股收益-0.07-0.59-0.38-0.22
  (二)稀释每股收益-0.07-0.59-0.38-0.22
九、综合收益总额-11,552,575.81-100,128,809.03-62,281,376.08-36,944,042.52
  归属于母公司股东的综合收益总额-13,428,863.82-114,401,033.12-73,617,048.63-43,131,623.44
  归属于少数股东的综合收益总额1,876,288.0114,272,224.0911,335,672.556,187,580.92
公告日期2026-04-242026-04-032025-10-282025-08-28
审计意见(境内)标准无保留意见
TOP↑